Carson Wealth (CWM LLC)
ENTA icon

Carson Wealth (CWM LLC)’s Enanta Pharmaceuticals ENTA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Buy
21,941
+1,275
+6% +$17.1K ﹤0.01% 2444
2025
Q4 		$326K Buy
20,666
+19
+0.1% +$241 ﹤0.01% 2203
2025
Q3 		$247K Sell
20,647
-817
-4% -$6.53K ﹤0.01% 2279
2025
Q2 		$162K Buy
21,464
+3,879
+22% +$23.3K ﹤0.01% 2357
2025
Q1 		$97K Buy
17,585
+15,549
+764% +$96K ﹤0.01% 2447
2024
Q4 		$12K Buy
2,036
+1,700
+506% +$16.3K ﹤0.01% 3750
2024
Q3 		$3K Buy
336
+32
+11% +$418 ﹤0.01% 4264
2024
Q2 		$4K Buy
304
+14
+5% +$189 ﹤0.01% 3945
2024
Q1 		$5K Sell
290
-36
-11% -$476 ﹤0.01% 3644
2023
Q4 		$3K Sell
326
-1,174
-78% -$10.9K ﹤0.01% 3683
2023
Q3 		$17K Buy
1,500
+1,200
+400% +$19.3K ﹤0.01% 2783
2023
Q2 		$6K Buy
300
+179
+148% +$5.28K ﹤0.01% 3338
2023
Q1 		$5K Sell
121
-19
-14% -$907 ﹤0.01% 3276
2022
Q4 		$7K Buy
140
+83
+146% +$3.78K ﹤0.01% 2993
2022
Q3 		$3K Hold
57
– – ﹤0.01% 3288
2022
Q2 		$3K Buy
57
+54
+1,800% +$2.93K ﹤0.01% 3186
2022
Q1 		$0 Sell
3
-4
-57% -$260 ﹤0.01% 3608
2021
Q4 		$1K Buy
+7
New +$549 ﹤0.01% 3288

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ENTA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Enanta Pharmaceuticals (ENTA) stake by 6.2% in Q1 2026, buying an estimated $17.1K and bringing the position to 21,941 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2444.

Carson Wealth (CWM LLC) first reported a position in ENTA in Q4 2021 and has held it in 18 quarters since. The position peaked at $326K in Q4 2025. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 21,941 shares of Enanta Pharmaceuticals worth $277K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 1,275 Enanta Pharmaceuticals shares in Q1 2026, an estimated $17.1K.
  • Enanta Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2444 holding.
  • Carson Wealth (CWM LLC) first reported a position in Enanta Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Enanta Pharmaceuticals position peaked at $326K in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.